Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild to Moderate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00281814
What this trial is testing

Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
The Cleveland Clinic 36
Not applicableUnknownNCT05271487
What this trial is testing

A Botanical Skin Care Regimen on Mild to Moderate Acne and the Microbiome

Who this might be right for
Acne Vulgaris
Integrative Skin Science and Research 20
Large-scale testing (Phase 3)Study completedNCT00139698
What this trial is testing

Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Pfizer 410
Large-scale testing (Phase 3)Study completedNCT00185172
What this trial is testing

Olmesartan in Essential Hypertension

Who this might be right for
Essential Hypertension
Sankyo Pharma Gmbh 2,333
Early research (Phase 1)Ended earlyNCT01975688
What this trial is testing

A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced Mucositis

Who this might be right for
Head and Neck Squamous Cell Carcinoma
GW Pharmaceuticals Ltd 10
Post-approval studies (Phase 4)Study completedNCT00137072
What this trial is testing

Mild To Moderate Erectile Dysfunction Study

Who this might be right for
Impotence
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 355
Not applicableActive Not RecruitingNCT06052995
What this trial is testing

Observational Study to Evaluate Use of Elidel® in South and East Asian Pediatric Patients With Atopic Dermatitis.

Who this might be right for
Mild to Moderate Atopic Dermatitis
BGP Products Operations GmbH, a Viatris company 130
Post-approval studies (Phase 4)Looking for participantsNCT04314375
What this trial is testing

Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Bausch Health Americas, Inc. 70
Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Large-scale testing (Phase 3)Study completedNCT00643227
What this trial is testing

A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Clarithromycin Extended Release for the Treatment of Pneumonia in Adult Patients

Who this might be right for
Pneumonia
Pfizer 504
Testing effectiveness (Phase 2)Study completedNCT04603027
What this trial is testing

Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis

Who this might be right for
PsoriasisPlaque Psoriasis
Evelo Biosciences, Inc. 249
Not applicableLooking for participantsNCT07178769
What this trial is testing

Study To Evaluate The Efficacy And Safety Of A Nutritional Supplement Based On Bergamot, Artichoke And Other Ingredients For Reducing Cholesterol Levels In Patients With Hypercholesterolemia (Metachol+)

Who this might be right for
Cholesterolemia
Laboratoires Arkopharma 207
Not applicableStudy completedNCT05483205
What this trial is testing

Normaderm Phytosolution Global Observational Study

Who this might be right for
Acne, Adult
Cosmetique Active International 2,827
Testing effectiveness (Phase 2)Study completedNCT02838069
What this trial is testing

A Study Evaluating the Efficacy of a Single Injection Autologous Adipose Derived Mesenchymal Stromal Cells in Patients With Knee Osteoarthritis

Who this might be right for
Osteoarthritis
University Hospital, Montpellier 100
Early research (Phase 1)Study completedNCT01266941
What this trial is testing

Assess the Effects of Fluticasone Furoate and GW642444M Combination in Healthy Subjects and in Subjects With Mild, Moderate or Severe Hepatic Impairment.

Who this might be right for
Asthma
GlaxoSmithKline 35
Testing effectiveness (Phase 2)Study completedNCT00005854
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00786994
What this trial is testing

The Efficacy and Tolerability of Oleogel-S-10 in Patients With Actinic Keratoses

Who this might be right for
Actinic Keratoses
Birken AG 165
Early research (Phase 1)Study completedNCT03765294
What this trial is testing

Investigate the Effects of ACT-541468 on Nighttime Respiratory Function in Patients With Mild to Moderate Obstructive Sleep Apnea

Who this might be right for
Obstructive Sleep Apnea
Idorsia Pharmaceuticals Ltd. 28
Early research (Phase 1)Ended earlyNCT04678505
What this trial is testing

Study of a Single Intravenous (IV) Dose of MK-3402 in Participants With Impaired Renal Function and in Healthy Controls (MK-3402-004)

Who this might be right for
Renal Impairment
Merck Sharp & Dohme LLC 9
Testing effectiveness (Phase 2)Study completedNCT01501942
What this trial is testing

Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Oral Administration of AIM-102 in Patients With Mild to Moderate Allergic Asthma

Who this might be right for
Asthma
AIM Therapeutics Inc. 11
Next Page